Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3510
-0.0080 (-2.22%)
Oct 7, 2025, 4:00 PM EDT - Market closed
Vaxart Market Cap
Vaxart has a market cap or net worth of $80.18 million as of October 7, 2025. Its market cap has decreased by -61.09% in one year.
Market Cap
80.18M
Enterprise Value
73.91M
1-Year Change
-61.09%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $80.18M, an increase of 32.86%. That is a compound annual growth rate of 3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 82.00M | -45.55% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.57B |
| Johnson & Johnson | 453.73B |
| AbbVie | 410.78B |
| UnitedHealth Group | 327.26B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.87B |